Arkolith/Insider Trading/RPRX/Form 4

Norden Gregory

DirectorRoyalty Pharma plc (RPRX) · full profile →Form 4 · filed Aug 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.2M
Net Open-Market Flow
-$1.2M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2025Sell(S)34K$36.23$1.2M195K
Aug 8, 2025Conversion(C)145K—$0228K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 8, 2025Conversion(C)14K—$00

Transaction Codes

S
Open-market sale
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001802768-25-000107) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML